- Gentlemen, start your drones: Judge’s ruling opens door for commercial use
- Soldier who hid, bragged about not saluting flag to be punished — in secret
- ‘Maverick’ of the seas: ‘Top Gun’ school for U.S. ship officers to launch
- Putin declares Sochi Paralympics open amid Ukrainian protest
- ‘In Jesus name, we pray’ sparks ire at Ohio council meeting
- Navy’s first laser weapon ready for prime time; drone killer to deploy this summer
- Billionaire backer: Rick Santorum ‘needs to be heard’ in 2016
- Obamacare fallout: 49 percent pessimistic; 45 percent ‘scared’
- DHS accused of holding U.S. citizen at airport, using emails to pry into her sex life
- Seattle socialist: Minimum-wage discussion skewed by ‘right-wing’ GAO analysis
Taxpayers must pay the freight for over-budget train projects
Topic - John Lechleiter
South Bend Tribune. Jan. 17, 2014.
The head of a drug manufacturer that lobbied on behalf of "Obamacare" now has come out swinging on one key aspect of the plan — the requirement for more tax rebates for dual Medicaid-Medicare recipients.
"I think many people would be surprised if they saw the high-tech nature of manufacturing in our industry and other industries today," Lechleiter said at the forum.
Eli Lilly & Co. CEO John Lechleiter said the "dual-eligible" aspect of Obamacare is all wrong for industry innovation and advancement, The Daily Caller reported.